0001415889-24-019276.txt : 20240703 0001415889-24-019276.hdr.sgml : 20240703 20240703181938 ACCESSION NUMBER: 0001415889-24-019276 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240701 FILED AS OF DATE: 20240703 DATE AS OF CHANGE: 20240703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Howe Jolanda CENTRAL INDEX KEY: 0001974200 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38981 FILM NUMBER: 241101205 MAIL ADDRESS: STREET 1: C/O MIRUM PHARMACEUTICALS, INC. STREET 2: 950 TOWER LANE, SUITE 1050 CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirum Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001759425 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 831281555 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 989 EAST HILLSDALE BOULEVARD, SUITE 300 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650-667-4085 MAIL ADDRESS: STREET 1: 989 EAST HILLSDALE BOULEVARD, SUITE 300 CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 form4-07032024_100734.xml X0508 4 2024-07-01 0001759425 Mirum Pharmaceuticals, Inc. MIRM 0001974200 Howe Jolanda C/O MIRUM PHARMACEUTICALS, INC. 989 E HILLSDALE BLVD., SUITE 300 FOSTER CITY CA 94404 false true false false SVP, GLOBAL CONTROLLER 0 Common Stock 2024-07-01 4 M 0 1042 A 2801 D Common Stock 2024-07-02 4 S 0 375 34 D 2426 D Restricted Stock Units 2024-07-01 4 M 0 1042 0 D Common Stock 1042 1041 D Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. The restricted stock units vest in a series of three successive equal annual installments beginning July 1, 2023. /s/ Judit Ryvkin, Attorney-in-Fact 2024-07-03